CERo Historical Balance Sheet
| CEROW Stock | 0.01 0 14.29% |
Trend analysis of CERo Therapeutics Holdings balance sheet accounts such as Short Long Term Debt Total of 1.5 M, Other Current Liabilities of 56.7 K or Total Current Liabilities of 4.9 M provides information on CERo Therapeutics' total assets, liabilities, and equity, which is the actual value of CERo Therapeutics to its prevalent stockholders. By breaking down trends over time using CERo Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining CERo Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CERo Therapeutics is a good buy for the upcoming year.
CERo |
About CERo Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of CERo Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. CERo Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CERo Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CERo currently owns. An asset can also be divided into two categories, current and non-current.
CERo Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of CERo Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CERo Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on CERo Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CERo Therapeutics Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Cash
Cash refers to the most liquid asset of CERo Therapeutics, which is listed under current asset account on CERo Therapeutics Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from CERo Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different CERo Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most accounts from CERo Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into CERo Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
| 2010 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 3.6M | 650K | 1.6M | 1.5M | Total Assets | 180.1M | 42.4M | 8.6M | 8.1M |
CERo Therapeutics balance sheet Correlations
Click cells to compare fundamentals
CERo Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.